These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31536377)

  • 1. Genome-bound enzymes as epigenetic drug targets in cancer.
    Bomsztyk K; Wang Y
    Epigenomics; 2019 Oct; 11(13):1463-1467. PubMed ID: 31536377
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting components of epigenome by small molecules.
    You JS; Han JH
    Arch Pharm Res; 2014 Nov; 37(11):1367-74. PubMed ID: 25070764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Targets and their Inhibitors in Cancer Therapy.
    Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
    Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic opportunities and challenges in cancer.
    Best JD; Carey N
    Drug Discov Today; 2010 Jan; 15(1-2):65-70. PubMed ID: 19897050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Regulation and Drug Discovery for Cancer Therapy.
    Yu B; Ouyang L
    Curr Top Med Chem; 2019; 19(12):971. PubMed ID: 31486748
    [No Abstract]   [Full Text] [Related]  

  • 9. Substituted purine and 7-deazapurine compounds as modulators of epigenetic enzymes: a patent evaluation (WO2012075381).
    Lipka DB; Kuck D; Kliem C; Gerhauser C
    Expert Opin Ther Pat; 2013 Apr; 23(4):537-43. PubMed ID: 23448241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
    Zhou Z; Li HQ; Liu F
    Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
    Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
    Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic cancer therapy makes headway.
    Mack GS
    J Natl Cancer Inst; 2006 Oct; 98(20):1443-4. PubMed ID: 17047192
    [No Abstract]   [Full Text] [Related]  

  • 13. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application.
    Santini V; Gozzini A; Ferrari G
    Curr Drug Metab; 2007 May; 8(4):383-93. PubMed ID: 17504226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches on epigenetics.
    Papait R; Monti E; Bonapace IM
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):264-75. PubMed ID: 19333872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors.
    Yang AS; Yang BJ
    Epigenomics; 2016 Jan; 8(1):9-12. PubMed ID: 26698294
    [No Abstract]   [Full Text] [Related]  

  • 18. Epigenetic therapies reach main street.
    Bates SE
    Clin Cancer Res; 2009 Jun; 15(12):3917. PubMed ID: 19528089
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical inhibitors make their RNA epigenetic mark.
    Cully M
    Nat Rev Drug Discov; 2019 Nov; 18(12):892-894. PubMed ID: 31780844
    [No Abstract]   [Full Text] [Related]  

  • 20. The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy.
    Liu N; Zhao R; Ma Y; Wang D; Yan C; Zhou D; Yin F; Li Z
    Curr Top Med Chem; 2018; 18(28):2380-2394. PubMed ID: 30430946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.